-
Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial
Mahomed, S., Garrett, N., Potloane, D., Sikazwe, I. T., Capparelli, E., Harkoo, I., Gengiah, T. N., Zuma, N. Y., Osman, F., Mansoor, L., Archary, D., Myeni, N., Radebe, P., Samsunder, N., Rose, N. D., Carlton, K., Gama, L., Koup, R. A., Narpala, S., Serebryannyy, L., & 7 others , 28 Aug 2023, In: BMJ Open. 13, 8, p. e076843 9 p., e076843.Research output: Contribution to journal › Article › Academic › peer-review
-
Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimens
the COVID-19 Immunity Task Force (CITF) working group, Sept 2022, In: Heliyon. 8, 9, 12 p., e10270.Research output: Contribution to journal › Article › Academic › peer-review
-
Re: Frisch & Simonson. Non-therapeutic male circumcision in infancy or childhood and risk of human immunodeficiency virus and other sexually transmitted infections: national cohort study in Denmark
Meyrowitsch, D. W., Andersen, L. S., Lohse, N., von Euler-Chelpin, M. & Hankins, C., 20 Jun 2022, In: European Journal of Epidemiology. 37, p. 651-652 2 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications